GS

Gilead Sciences Portfolio holdings

AUM $1.28B
This Quarter Return
-20.18%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$1.18B
AUM Growth
+$1.18B
Cap. Flow
-$119M
Cap. Flow %
-10.09%
Top 10 Hldgs %
99.56%
Holding
16
New
Increased
1
Reduced
3
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ACLX icon
1
Arcellx
ACLX
$3.85B
$441M 37.32% 6,720,803
GLPG icon
2
Galapagos
GLPG
$2.07B
$419M 35.5% 16,707,477
RCUS icon
3
Arcus Biosciences
RCUS
$1.13B
$247M 20.88% 31,424,760 +1,363,636 +5% +$10.7M
ASMB icon
4
Assembly Biosciences
ASMB
$190M
$21.1M 1.79% 2,209,471
MRUS icon
5
Merus
MRUS
$4.98B
$19M 1.61% 452,527
KYTX icon
6
Kyverna Therapeutics
KYTX
$160M
$7.96M 0.67% 4,126,119
TNGX icon
7
Tango Therapeutics
TNGX
$747M
$6.65M 0.56% 4,854,443
XLO icon
8
Xilio Therapeutics
XLO
$36.3M
$6.6M 0.56% 9,105,451
KLRS
9
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
$5.81M 0.49% 723,273 -15,912,013 -96% -$128M
HOOK
10
DELISTED
HOOKIPA Pharma
HOOK
$2.03M 0.17% 1,875,945
ALLO icon
11
Allogene Therapeutics
ALLO
$251M
$1.69M 0.14% 1,156,689
LPTX icon
12
Leap Therapeutics
LPTX
$12M
$1.62M 0.14% 5,319,148
IMA
13
ImageneBio, Inc. Common Stock
IMA
$150M
$1.48M 0.13% 1,159,145 -849,193 -42% -$1.09M
BRNS
14
Barinthus Biotherapeutics
BRNS
$45.6M
$360K 0.03% 369,855 -250,496 -40% -$244K
AGEN
15
Agenus
AGEN
$133M
-231,663 Closed -$635K
KRON
16
DELISTED
Kronos Bio
KRON
-188,567 Closed -$179K